Visceral Fat Reduction
Define
Tesamorelin
Product images are illustrative. Orders are dispensed and shipped by our partner pharmacy in standard pharmacy vials and pens with pharmacy labeling.
Research OnlyProduct images are illustrative. Orders are dispensed and shipped by our partner pharmacy in standard pharmacy vials and pens with pharmacy labeling.
Research OnlySelect Format
Select Strength
$349 — 1-month supply. Includes your protocol and direct shipping.
✦Want a protocol built around your biology?
Add Precision — lab testing + provider-guided optimization.
These products are sold for Research Use Only (RUO). They are not intended for human or veterinary use, or for diagnosis, treatment, or prevention of any disease. By purchasing, you confirm you are a qualified researcher and will use these materials solely for laboratory research.
Tesamorelin is a GHRH analog that has been studied for visceral adipose tissue reduction.
- ✓Targets visceral fat
- ✓FDA-Approved Active Ingredient
- ✓Subcutaneous injection
- ✓Cardiometabolic support
How It Works
Mimics the body's own GHRH to stimulate pulsatile GH release, which selectively reduces visceral adipose tissue.
Best paired with: Sermorelin, NAD+, CJC-1295
What Happens Next
- 1Complete checkout
- 2Order confirmed
- 3Prepared and shipped from a US facility
Research-use-only products are not subject to provider review — orders are prepared and shipped directly.
Why Researchers Choose Define
- ✓Active ingredient is FDA-approved (Egrifta) — one of the most studied GHRH analogs
- ✓Selectively targets visceral adipose tissue — the metabolically dangerous fat around organs
- ✓Stimulates pulsatile GH release without exogenous hormone replacement
- ✓Supports cardiometabolic markers alongside body composition goals
Intended for research applications in visceral fat and metabolic support.
Complete Your Protocol
Patients often combine Define with these add-ons for enhanced results.
